Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics

PURPOSETo examine cancer patients' perspectives on the impact of COVID-19 on teleoncology in Nigeria.METHODSData from a multicenter survey conducted at 15 outpatient clinics to 1,097 patients with cancer from April and July 2020 were analyzed. The study outcome was telemedicine, defined as pati...

Full description

Bibliographic Details
Main Authors: Adedayo Joseph, Abdul R. Shour, Nwamaka N. Lasebikan, Mutiu A. Jimoh, Bolanle C. Adegboyega, Emmanuella Nwachukwu, Opeyemi Awofeso, Azeezat Ajose, Abiola Ibraheem, Omolara Aminat Fatiregun, Musa Ali-Gombe, Usman M. Aliyu, Abdallah Elsaid Kotkat, Olusegun Abayomi Biyi-Olutunde, Evaristus Oseiwe Oboh, Ismail H. Zubairu, Mohammad Rifat Haider, Bankole Olatosi, David Puthoff, Adedayo A. Onitilo
Format: Article
Language:English
Published: American Society of Clinical Oncology 2023-03-01
Series:JCO Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/GO.22.00221
_version_ 1797870043256586240
author Adedayo Joseph
Abdul R. Shour
Nwamaka N. Lasebikan
Mutiu A. Jimoh
Bolanle C. Adegboyega
Emmanuella Nwachukwu
Opeyemi Awofeso
Azeezat Ajose
Abiola Ibraheem
Omolara Aminat Fatiregun
Musa Ali-Gombe
Usman M. Aliyu
Abdallah Elsaid Kotkat
Olusegun Abayomi Biyi-Olutunde
Evaristus Oseiwe Oboh
Ismail H. Zubairu
Mohammad Rifat Haider
Bankole Olatosi
David Puthoff
Adedayo A. Onitilo
author_facet Adedayo Joseph
Abdul R. Shour
Nwamaka N. Lasebikan
Mutiu A. Jimoh
Bolanle C. Adegboyega
Emmanuella Nwachukwu
Opeyemi Awofeso
Azeezat Ajose
Abiola Ibraheem
Omolara Aminat Fatiregun
Musa Ali-Gombe
Usman M. Aliyu
Abdallah Elsaid Kotkat
Olusegun Abayomi Biyi-Olutunde
Evaristus Oseiwe Oboh
Ismail H. Zubairu
Mohammad Rifat Haider
Bankole Olatosi
David Puthoff
Adedayo A. Onitilo
author_sort Adedayo Joseph
collection DOAJ
description PURPOSETo examine cancer patients' perspectives on the impact of COVID-19 on teleoncology in Nigeria.METHODSData from a multicenter survey conducted at 15 outpatient clinics to 1,097 patients with cancer from April and July 2020 were analyzed. The study outcome was telemedicine, defined as patients who reported their routine follow-up visits were converted to virtual visits because of COVID-19 (coded yes/no). Covariates included patient age, ethnicity, marital status, income, cancer treatment, service disruption, and cancer diagnosis/type. Stata/SE.v.17 (StataCorp, College Station, TX) was used to perform chi-square and logistic regression analyses. P values ≤ .05 were considered statistically significant.RESULTSThe majority of the 1,097 patients with cancer were female (65.7%) and age 55 years and older (35.0%). Because of COVID-19, 12.6% of patients' routine follow-ups were converted to virtual visits. More patients who canceled/postponed surgery (17.7% v 7.5%; P ≤ .001), radiotherapy (16.9% v 5.3%; P ≤ .001), and chemotherapy (22.8% v 8.5%; P ≤ .001), injection chemotherapy (20.6% v 8.7%; P ≤ .001) and those who reported being seen less by their doctor/nurse (60.3% v 11.4%; P ≤ .001) reported more follow-up conversions to virtual visits. In multivariate analyses, patients seen less by their doctors/nurses were 14.3 times more likely to have their routine follow-ups converted to virtual visits than those who did not (odds ratio, 14.33; 95% CI, 8.36 to 24.58).CONCLUSIONCOVID-19 caused many patients with cancer in Nigeria to convert visits to a virtual format. These conversions were more common in patients whose surgery, radiotherapy, chemotherapy, and injection chemotherapy treatments were canceled or postponed. Our findings suggest how COVID-19 affects cancer treatment services and the importance of collecting teleoncological care data in Nigeria.
first_indexed 2024-04-10T00:22:11Z
format Article
id doaj.art-7a94a34357f04490b37986d367735c4d
institution Directory Open Access Journal
issn 2687-8941
language English
last_indexed 2024-04-10T00:22:11Z
publishDate 2023-03-01
publisher American Society of Clinical Oncology
record_format Article
series JCO Global Oncology
spelling doaj.art-7a94a34357f04490b37986d367735c4d2023-03-15T19:59:01ZengAmerican Society of Clinical OncologyJCO Global Oncology2687-89412023-03-01910.1200/GO.22.00221Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer ClinicsAdedayo Joseph0Abdul R. Shour1Nwamaka N. Lasebikan2Mutiu A. Jimoh3Bolanle C. Adegboyega4Emmanuella Nwachukwu5Opeyemi Awofeso6Azeezat Ajose7Abiola Ibraheem8Omolara Aminat Fatiregun9Musa Ali-Gombe10Usman M. Aliyu11Abdallah Elsaid Kotkat12Olusegun Abayomi Biyi-Olutunde13Evaristus Oseiwe Oboh14Ismail H. Zubairu15Mohammad Rifat Haider16Bankole Olatosi17David Puthoff18Adedayo A. Onitilo19NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, NigeriaCancer Care and Research Center, Marshfield Clinic Health System, Marshfield, WIUniversity of Nigeria Teaching Hospital, Enugu, NigeriaUniversity College Hospital, Ibadan, NigeriaNSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, NigeriaNational Hospital, Abuja, NigeriaHarvard Medical School, Boston, MAHarvard Medical School, Boston, MADivision of Hematology & Oncology, University of Illinois College of Medicine, Chicago, ILLagos State University Teaching Hospital (LASUTH), Lagos, NigeriaFederal Teaching Hospital, Gombe, NigeriaUsman Danfodiyo University Teaching Hospital, Sokoto, NigeriaNSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, NigeriaUniversity of Port-Harcourt Teaching Hospital, Rivers State, NigeriaUniversity of Benin Teaching Hospital, Edo, NigeriaAhmadu Bello University Teaching Hospital, Kaduna, NigeriaCancer Care and Research Center, Marshfield Clinic Health System, Marshfield, WIMarshfield Clinic Research Institute, Marshfield Clinic Health System, Marshfield, WIMarshfield Clinic Research Institute, Marshfield Clinic Health System, Marshfield, WICancer Care and Research Center, Marshfield Clinic Health System, Marshfield, WIPURPOSETo examine cancer patients' perspectives on the impact of COVID-19 on teleoncology in Nigeria.METHODSData from a multicenter survey conducted at 15 outpatient clinics to 1,097 patients with cancer from April and July 2020 were analyzed. The study outcome was telemedicine, defined as patients who reported their routine follow-up visits were converted to virtual visits because of COVID-19 (coded yes/no). Covariates included patient age, ethnicity, marital status, income, cancer treatment, service disruption, and cancer diagnosis/type. Stata/SE.v.17 (StataCorp, College Station, TX) was used to perform chi-square and logistic regression analyses. P values ≤ .05 were considered statistically significant.RESULTSThe majority of the 1,097 patients with cancer were female (65.7%) and age 55 years and older (35.0%). Because of COVID-19, 12.6% of patients' routine follow-ups were converted to virtual visits. More patients who canceled/postponed surgery (17.7% v 7.5%; P ≤ .001), radiotherapy (16.9% v 5.3%; P ≤ .001), and chemotherapy (22.8% v 8.5%; P ≤ .001), injection chemotherapy (20.6% v 8.7%; P ≤ .001) and those who reported being seen less by their doctor/nurse (60.3% v 11.4%; P ≤ .001) reported more follow-up conversions to virtual visits. In multivariate analyses, patients seen less by their doctors/nurses were 14.3 times more likely to have their routine follow-ups converted to virtual visits than those who did not (odds ratio, 14.33; 95% CI, 8.36 to 24.58).CONCLUSIONCOVID-19 caused many patients with cancer in Nigeria to convert visits to a virtual format. These conversions were more common in patients whose surgery, radiotherapy, chemotherapy, and injection chemotherapy treatments were canceled or postponed. Our findings suggest how COVID-19 affects cancer treatment services and the importance of collecting teleoncological care data in Nigeria.https://ascopubs.org/doi/10.1200/GO.22.00221
spellingShingle Adedayo Joseph
Abdul R. Shour
Nwamaka N. Lasebikan
Mutiu A. Jimoh
Bolanle C. Adegboyega
Emmanuella Nwachukwu
Opeyemi Awofeso
Azeezat Ajose
Abiola Ibraheem
Omolara Aminat Fatiregun
Musa Ali-Gombe
Usman M. Aliyu
Abdallah Elsaid Kotkat
Olusegun Abayomi Biyi-Olutunde
Evaristus Oseiwe Oboh
Ismail H. Zubairu
Mohammad Rifat Haider
Bankole Olatosi
David Puthoff
Adedayo A. Onitilo
Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics
JCO Global Oncology
title Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics
title_full Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics
title_fullStr Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics
title_full_unstemmed Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics
title_short Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics
title_sort examining cancer patients perceptions of the impact of covid 19 on teleoncology findings from 15 nigerian outpatient cancer clinics
url https://ascopubs.org/doi/10.1200/GO.22.00221
work_keys_str_mv AT adedayojoseph examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT abdulrshour examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT nwamakanlasebikan examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT mutiuajimoh examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT bolanlecadegboyega examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT emmanuellanwachukwu examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT opeyemiawofeso examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT azeezatajose examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT abiolaibraheem examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT omolaraaminatfatiregun examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT musaaligombe examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT usmanmaliyu examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT abdallahelsaidkotkat examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT olusegunabayomibiyiolutunde examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT evaristusoseiweoboh examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT ismailhzubairu examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT mohammadrifathaider examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT bankoleolatosi examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT davidputhoff examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics
AT adedayoaonitilo examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics